中国とRCEP諸国からのデータに基づく経験的分析
Liang Wu1, Wenxia Liu1, Jianhua Zhou1
1School of Economics and Management, Huzhou University, Huzhou, China.
Frontiers in public health
|August 29, 2025
まとめ
RCEP諸国への中国の医療製品の輸出は増加しており,効率の向上により,医療サービスの改善により人間の発展が促進されています. 政策立案者や輸出者はこの"貿易・健康・開発"のつながりを強化することができます.
科学分野:
- 健康 経済
- 国際貿易
- 公衆衛生政策
背景:
- 地域包括経済パートナーシップ協定 (RCEP) の成長は,医療製品の貿易が地域保健安全保障と経済発展にとって重要であることを強調しています.
- 医療製品貿易のダイナミクスを理解することは,RCEP諸国の公衆衛生と経済発展の両方にとって極めて重要です.
研究 の 目的:
- RCEP加盟国の開発指数に対する中国の医療製品輸出効率の影響を分析する.
- RCEP地域における中国の医療製品輸出の主要な要因と特徴を特定する.
主な方法:
- ストキャスティック・フロンティア・グラビティ・モデルとベンチマーク・リグレーション・モデルを使用した.
- 2004年から2023年までのデータを分析した.
主要な成果:
- RCEPへの中国の医療製品の輸出は,ASEAN,日本,韓国での規模拡大,構造的差別化,市場集中を示しています.
- 貿易効率は,制度的要因 (ガバナンス,保健システム) と技術的能力によって影響を受け,自由化と税務負担が課題となっている.
- 輸出効率の向上は,RCEP諸国における基本的保健サービス提供の拡大を通じて,貿易・健康・開発の経路を確立することで,人間開発に好ましい影響を及ぼします.
結論:
- 政策立案者向けに制度的調整の深化と"貿易・健康"の共同ガバナンス枠組みの確立を推奨する.
- 輸出業者は段階的な市場戦略を採用し,産業の回復力を高めるために技術革新に投資することをお勧めします.
関連する概念動画
01:52Regression Toward the Mean
6.5K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.5K
01:12Analysis of Population Pharmacokinetic Data
382
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
382
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
01:26Methods Of Healthcare Delivery System
3.5K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.5K
01:23Mechanistic Models: Compartment Models in Individual and Population Analysis
85
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
85
01:12Hazard Ratio
241
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
241